Rajan Sharma
Stock Analyst at Goldman Sachs
(0.27)
# 4,227
Out of 4,905 analysts
5
Total ratings
25%
Success rate
-13.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $10.00 | -27.50% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $68.79 | +41.01% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $36.31 | +29.44% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $36.32 | +117.51% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $10.00
Upside: -27.50%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $68.79
Upside: +41.01%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $36.31
Upside: +29.44%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $36.32
Upside: +117.51%